A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 103 participants.

Also called NCT07474649

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 103 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07474649
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany, Italy, Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07474649. Allocation not applicable; no masking; primary purpose treatment. Start 2026-09-14 (actual); primary completion 2028-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events
Condition
Coronary Atherosclerosis
Condition
Mixed Dyslipidemia
Condition
Hypercholesterolemia
Intervention (Drug)
Bempedoic acid
Intervention (Drug)
Ezetimibe
Intervention (Drug)
Rosuvastatin
Intervention (Drug)
Atorvastatin
Lead sponsor
Daiichi Sankyo (class: industry)

Record details

Record id
cardio:ct-nct07474649
Content hash
feab97290471b4c7d0d38f52e2effb6e198c70da30bfa7dc9d328248a9906542